{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:19:27Z","timestamp":1792181967520,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Triumph Over Kid Cancer Foundation","award":["PS104386"],"award-info":[{"award-number":["PS104386"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ewing sarcoma is a malignancy of primitive cells, possibly of mesenchymal origin. It is probable that genetic perturbations other than <jats:italic>EWS-FLI1<\/jats:italic> cooperate with it to produce the tumor. Sequencing studies identified <jats:italic>STAG2<\/jats:italic> mutations in approximately 15% of cases in humans. In the present study, we hypothesize that loss of <jats:italic>Stag2<\/jats:italic> cooperates with <jats:italic>EWS-FLI1<\/jats:italic> in generating sarcomas derived from murine mesenchymal stem cells (MSCs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Mice bearing an inducible <jats:italic>EWS-FLI1<\/jats:italic> transgene were crossed to <jats:italic>p53<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice in pure C57\/Bl6 background. MSCs were derived from the bone marrow of the mice. <jats:italic>EWS-FLI1<\/jats:italic> induction and <jats:italic>Stag2<\/jats:italic> knockdown were achieved in vitro by adenovirus-Cre and shRNA-bearing pGIPZ lentiviral infection, respectively. The cells were then treated with ionizing radiation to 10\u2009Gy. Anchorage independent growth in vitro was assessed by soft agar assays. Cellular migration and invasion were evaluated by transwell assays. Cells were injected with Matrigel intramuscularly into C57\/Bl6 mice to test for tumor formation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Primary murine MSCs with the genotype <jats:italic>EWS-FLI1 p53<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> were resistant to transformation and did not form tumors in syngeneic mice without irradiation. <jats:italic>Stag2<\/jats:italic> inhibition increased the efficiency and speed of sarcoma formation significantly in irradiated <jats:italic>EWS-FLI1 p53<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> MSCs. The efficiency of tumor formation was 91% for cells in mice injected with <jats:italic>Stag2<\/jats:italic>-repressed cells and 22% for mice receiving cells without <jats:italic>Stag2<\/jats:italic> inhibition (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001). <jats:italic>Stag2<\/jats:italic> knockdown reduced survival of mice in Kaplan-Meier analysis (p\u2009&lt;\u2009.001). It also increased MSC migration and invasion in vitro but did not affect proliferation rate or aneuploidy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Loss of <jats:italic>Stag2<\/jats:italic> has a synergistic effect with <jats:italic>EWS-FLI1<\/jats:italic> in the production of sarcomas from murine MSCs, but the mechanism may not relate to increased proliferation or chromosomal instability. Primary murine MSCs are resistant to transformation, and the combination of <jats:italic>p53<\/jats:italic> null mutation, <jats:italic>EWS-FLI1<\/jats:italic>, and <jats:italic>Stag2<\/jats:italic> inhibition does not confer immediate conversion of MSCs to sarcomas. Irradiation is necessary in this model, suggesting that perturbations of other genes beside <jats:italic>Stag2<\/jats:italic> and <jats:italic>p53<\/jats:italic> are likely to be essential in the development of <jats:italic>EWS-FLI1-<\/jats:italic>driven sarcomas from MSCs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-019-6465-8","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T13:02:44Z","timestamp":1577970164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells"],"prefix":"10.1186","volume":"20","author":[{"given":"Marc","family":"El Beaino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Wasylishen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Pourebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Migut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Bessellieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-4994","authenticated-orcid":false,"given":"Patrick P.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"issue":"17","key":"6465_CR1","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1200\/JCO.2000.18.17.3108","volume":"18","author":"SJ Cotterill","year":"2000","unstructured":"Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, Craft AW. Prognostic factors in Ewing\u2019s tumor of bone: analysis of 975 patients from the European intergroup cooperative Ewing\u2019s sarcoma study group. J Clin Oncol. 2000;18(17):3108\u201314.","journal-title":"J Clin Oncol"},{"issue":"2","key":"6465_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/cncr.22821","volume":"110","author":"C Rodriguez-Galindo","year":"2007","unstructured":"Rodriguez-Galindo C, Liu T, Krasin MJ, Wu J, Billups CA, Daw NC, Spunt SL, Rao BN, Santana VM, Navid F. Analysis of prognostic factors in Ewing sarcoma family of tumors: review of St. Jude Children\u2019s Research Hospital studies. Cancer. 2007;110(2):375\u201384.","journal-title":"Cancer"},{"issue":"1","key":"6465_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-4608(84)90002-5","volume":"12","author":"C Turc-Carel","year":"1984","unstructured":"Turc-Carel C, Philip I, Berger MP, Philip T, Lenoir GM. Chromosome study of Ewing\u2019s sarcoma (ES) cell lines. Consistency of a reciprocal translocation t (11;22)(q24;q12). Cancer Genet Cytogenet. 1984;12(1):1\u201319.","journal-title":"Cancer Genet Cytogenet"},{"issue":"6391","key":"6465_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/359162a0","volume":"359","author":"O Delattre","year":"1992","unstructured":"Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359(6391):162\u20135.","journal-title":"Nature"},{"issue":"2","key":"6465_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/1947601912457024","volume":"3","author":"A Chaturvedi","year":"2012","unstructured":"Chaturvedi A, Hoffman LM, Welm AL, Lessnick SL, Beckerle MC. The EWS\/FLI oncogene drives changes in cellular morphology, adhesion, and migration in Ewing sarcoma. Genes Cancer. 2012;3(2):102\u201316.","journal-title":"Genes Cancer"},{"issue":"12","key":"6465_CR6","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1073\/pnas.90.12.5752","volume":"90","author":"WA May","year":"1993","unstructured":"May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A. 1993;90(12):5752\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6465_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1073\/pnas.0607007104","volume":"104","author":"KP Ng","year":"2007","unstructured":"Ng KP, Potikyan G, Savene RO, Denny CT, Uversky VN, Lee KA. Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins. Proc Natl Acad Sci U S A. 2007;104(2):479\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6465_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fonc.2012.00107","volume":"2","author":"S Schlottmann","year":"2012","unstructured":"Schlottmann S, Erkizan HV, Barber-Rotenberg JS, Knights C, Cheema A, Uren A, Avantaggiati ML, Toretsky JA. Acetylation increases EWS-FLI1 DNA binding and transcriptional activity. Front Oncol. 2012;2:107.","journal-title":"Front Oncol"},{"issue":"42","key":"6465_CR9","doi-asserted-by":"publisher","first-page":"13579","DOI":"10.1021\/bi048776q","volume":"43","author":"A Uren","year":"2004","unstructured":"Uren A, Tcherkasskaya O, Toretsky JA. Recombinant EWS-FLI1 oncoprotein activates transcription. Biochemistry. 2004;43(42):13579\u201389.","journal-title":"Biochemistry"},{"issue":"11","key":"6465_CR10","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","volume":"4","author":"BD Crompton","year":"2014","unstructured":"Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS, et al. The genomic landscape of pediatric Ewing sarcoma. Cancer Discov. 2014;4(11):1326\u201341.","journal-title":"Cancer Discov"},{"issue":"11","key":"6465_CR11","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","volume":"4","author":"F Tirode","year":"2014","unstructured":"Tirode F, Surdez D, Ma X, Parker M, Le Deley MC, Bahrami A, Zhang Z, Lapouble E, Grossetete-Lalami S, Rusch M, et al. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov. 2014;4(11):1342\u201353.","journal-title":"Cancer Discov"},{"key":"6465_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1146\/annurev-genet-102108-134233","volume":"43","author":"K Nasmyth","year":"2009","unstructured":"Nasmyth K, Haering CH. Cohesin: its roles and mechanisms. Annu Rev Genet. 2009;43:525\u201358.","journal-title":"Annu Rev Genet"},{"issue":"4","key":"6465_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1083\/jcb.151.4.749","volume":"151","author":"I Sumara","year":"2000","unstructured":"Sumara I, Vorlaufer E, Gieffers C, Peters BH, Peters JM. Characterization of vertebrate cohesin complexes and their regulation in prophase. J Cell Biol. 2000;151(4):749\u201362.","journal-title":"J Cell Biol"},{"issue":"3","key":"6465_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1083\/jcb.150.3.405","volume":"150","author":"A Losada","year":"2000","unstructured":"Losada A, Yokochi T, Kobayashi R, Hirano T. Identification and characterization of SA\/Scc3p subunits in the Xenopus and human cohesin complexes. J Cell Biol. 2000;150(3):405\u201316.","journal-title":"J Cell Biol"},{"issue":"6","key":"6465_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/humu.21252","volume":"31","author":"L Mannini","year":"2010","unstructured":"Mannini L, Menga S, Musio A. The expanding universe of cohesin functions: a new genome stability caretaker involved in human disease and cancer. Hum Mutat. 2010;31(6):623\u201330.","journal-title":"Hum Mutat"},{"issue":"7202","key":"6465_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature07098","volume":"454","author":"CH Haering","year":"2008","unstructured":"Haering CH, Farcas AM, Arumugam P, Metson J, Nasmyth K. The cohesin ring concatenates sister DNA molecules. Nature. 2008;454(7202):297\u2013301.","journal-title":"Nature"},{"issue":"6045","key":"6465_CR17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1203619","volume":"333","author":"DA Solomon","year":"2011","unstructured":"Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT, Toretsky JA, Rosenberg SA, Shukla N, Ladanyi M, et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science. 2011;333(6045):1039\u201343.","journal-title":"Science"},{"issue":"6045","key":"6465_CR18","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1126\/science.1211154","volume":"333","author":"RD Kolodner","year":"2011","unstructured":"Kolodner RD, Cleveland DW, Putnam CD. Cancer. Aneuploidy drives a mutator phenotype in cancer. Science. 2011;333(6045):942\u20133.","journal-title":"Science"},{"issue":"5","key":"6465_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4149\/neo_2012_067","volume":"59","author":"MS Kim","year":"2012","unstructured":"Kim MS, Kim SS, Je EM, Yoo NJ, Lee SH. Mutational and expressional analyses of STAG2 gene in solid cancers. Neoplasma. 2012;59(5):524\u20139.","journal-title":"Neoplasma"},{"issue":"4","key":"6465_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.urology.2013.11.027","volume":"83","author":"P Black","year":"2014","unstructured":"Black P. Frequent truncating mutations of STAG2 in bladder cancer. Urology. 2014;83(4):691\u20132.","journal-title":"Urology"},{"issue":"2","key":"6465_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3892\/etm.2017.4030","volume":"13","author":"Q Han","year":"2017","unstructured":"Han Q, He X, Wu L, Gao F, Ye J, Wu L, Chen L, Jiang X, Sun M, Chen S. Downregulated stromal antigen 2 expression in de novo acute myeloid leukemia patients. Exp Ther Med. 2017;13(2):530\u20134.","journal-title":"Exp Ther Med"},{"issue":"12","key":"6465_CR22","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ng.2798","volume":"45","author":"G Guo","year":"2013","unstructured":"Guo G, Sun X, Chen C, Wu S, Huang P, Li Z, Dean M, Huang Y, Jia W, Zhou Q, et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet. 2013;45(12):1459\u201363.","journal-title":"Nat Genet"},{"issue":"8","key":"6465_CR23","doi-asserted-by":"publisher","first-page":"10279","DOI":"10.1007\/s13277-016-4894-4","volume":"37","author":"Y Qiao","year":"2016","unstructured":"Qiao Y, Zhu X, Li A, Yang S, Zhang J. Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer. Tumour Biol. 2016;37(8):10279\u201386.","journal-title":"Tumour Biol"},{"issue":"12","key":"6465_CR24","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/ng.2799","volume":"45","author":"C Balbas-Martinez","year":"2013","unstructured":"Balbas-Martinez C, Sagrera A, Carrillo-de-Santa-Pau E, Earl J, Marquez M, Vazquez M, Lapi E, Castro-Giner F, Beltran S, Bayes M, et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet. 2013;45(12):1464\u20139.","journal-title":"Nat Genet"},{"issue":"6287","key":"6465_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.aac7272","volume":"352","author":"C Lu","year":"2016","unstructured":"Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, Murphy D, Venneti S, Hameed M, Pawel BR, et al. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science. 2016;352(6287):844\u20139.","journal-title":"Science"},{"issue":"21","key":"6465_CR26","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1158\/0008-5472.CAN-08-0573","volume":"68","author":"PP Lin","year":"2008","unstructured":"Lin PP, Pandey MK, Jin F, Xiong S, Deavers M, Parant JM, Lozano G. EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model. Cancer Res. 2008;68(21):8968\u201375.","journal-title":"Cancer Res"},{"issue":"1","key":"6465_CR27","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.4238\/2015.March.30.24","volume":"14","author":"X Li","year":"2015","unstructured":"Li X, Zhang TW, Tang JL, Fa PP, Lu JX, Qi FM, Cai ZM, Liu CX, Sun XJ. Loss of STAG2 causes aneuploidy in normal human bladder cells. Genet Mol Res. 2015;14(1):2638\u201346.","journal-title":"Genet Mol Res"},{"issue":"2","key":"6465_CR28","doi-asserted-by":"publisher","first-page":"e1005865","DOI":"10.1371\/journal.pgen.1005865","volume":"12","author":"JS Kim","year":"2016","unstructured":"Kim JS, He X, Orr B, Wutz G, Hill V, Peters JM, Compton DA, Waldman T. Intact cohesion, anaphase, and chromosome segregation in human cells harboring tumor-derived mutations in STAG2. PLoS Genet. 2016;12(2):e1005865.","journal-title":"PLoS Genet"},{"issue":"2","key":"6465_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1172\/JCI117360","volume":"94","author":"M Giovannini","year":"1994","unstructured":"Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, Emanuel BS, Evans GA. EWS-erg and EWS-Fli1 fusion transcripts in Ewing\u2019s sarcoma and primitive neuroectodermal tumors with variant translocations. J Clin Invest. 1994;94(2):489\u201396.","journal-title":"J Clin Invest"},{"issue":"5","key":"6465_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1056\/NEJM199408043310503","volume":"331","author":"O Delattre","year":"1994","unstructured":"Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, et al. The Ewing family of tumors\u2013a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 1994;331(5):294\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"6465_CR31","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1200\/JCO.1999.17.6.1809","volume":"17","author":"JP Ginsberg","year":"1999","unstructured":"Ginsberg JP, de Alava E, Ladanyi M, Wexler LH, Kovar H, Paulussen M, Zoubek A, Dockhorn-Dworniczak B, Juergens H, Wunder JS, et al. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing\u2019s sarcoma. J Clin Oncol. 1999;17(6):1809\u201314.","journal-title":"J Clin Oncol"},{"issue":"6","key":"6465_CR32","first-page":"1229","volume":"10","author":"IS Jeon","year":"1995","unstructured":"Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN. A variant Ewing\u2019s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 1995;10(6):1229\u201334.","journal-title":"Oncogene"},{"issue":"2","key":"6465_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1098-2264(199602)15:2<115::AID-GCC6>3.0.CO;2-6","volume":"15","author":"Y Kaneko","year":"1996","unstructured":"Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F, Fujinaga K. Fusion of an ETS-family gene, EIAF, to EWS by t (17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosom Cancer. 1996;15(2):115\u201321.","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"6465_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/his.12281","volume":"64","author":"C Antonescu","year":"2014","unstructured":"Antonescu C. Round cell sarcomas beyond Ewing: emerging entities. Histopathology. 2014;64(1):26\u201337.","journal-title":"Histopathology"},{"issue":"12","key":"6465_CR35","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/sj.bjc.6603819","volume":"96","author":"SC Brownhill","year":"2007","unstructured":"Brownhill SC, Taylor C, Burchill SA. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. Br J Cancer. 2007;96(12):1914\u201323.","journal-title":"Br J Cancer"},{"issue":"6","key":"6465_CR36","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/cncr.22908","volume":"110","author":"K Honoki","year":"2007","unstructured":"Honoki K, Stojanovski E, McEvoy M, Fujii H, Tsujiuchi T, Kido A, Takakura Y, Attia J. Prognostic significance of p16 INK4a alteration for Ewing sarcoma: a meta-analysis. Cancer. 2007;110(6):1351\u201360.","journal-title":"Cancer"},{"issue":"7\u20138","key":"6465_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cancergen.2012.05.012","volume":"205","author":"MS Jahromi","year":"2012","unstructured":"Jahromi MS, Putnam AR, Druzgal C, Wright J, Spraker-Perlman H, Kinsey M, Zhou H, Boucher KM, Randall RL, Jones KB, et al. Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma. Cancer Genet. 2012;205(7\u20138):391\u2013404.","journal-title":"Cancer Genet"},{"issue":"10","key":"6465_CR38","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/onc.2011.317","volume":"31","author":"C Mackintosh","year":"2012","unstructured":"Mackintosh C, Ordonez JL, Garcia-Dominguez DJ, Sevillano V, Llombart-Bosch A, Szuhai K, Scotlandi K, Alberghini M, Sciot R, Sinnaeve F, et al. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene. 2012;31(10):1287\u201398.","journal-title":"Oncogene"},{"issue":"2","key":"6465_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cancergencyto.2007.11.002","volume":"181","author":"G Maire","year":"2008","unstructured":"Maire G, Brown CW, Bayani J, Pereira C, Gravel DH, Bell JC, Zielenska M, Squire JA. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review. Cancer Genet Cytogenet. 2008;181(2):81\u201392.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"6465_CR40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4161\/cc.7.2.5229","volume":"7","author":"JD Hancock","year":"2008","unstructured":"Hancock JD, Lessnick SL. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature. Cell Cycle. 2008;7(2):250\u20136.","journal-title":"Cell Cycle"},{"issue":"4","key":"6465_CR41","doi-asserted-by":"publisher","first-page":"e19305","DOI":"10.1371\/journal.pone.0019305","volume":"6","author":"C von Levetzow","year":"2011","unstructured":"von Levetzow C, Jiang X, Gwye Y, von Levetzow G, Hung L, Cooper A, Hsu JH, Lawlor ER. Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS One. 2011;6(4):e19305.","journal-title":"PLoS One"},{"issue":"7","key":"6465_CR42","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1128\/MCB.00740-07","volume":"28","author":"Y Miyagawa","year":"2008","unstructured":"Miyagawa Y, Okita H, Nakaijima H, Horiuchi Y, Sato B, Taguchi T, Toyoda M, Katagiri YU, Fujimoto J, Hata J, et al. Inducible expression of chimeric EWS\/ETS proteins confers Ewing\u2019s family tumor-like phenotypes to human mesenchymal progenitor cells. Mol Cell Biol. 2008;28(7):2125\u201337.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"6465_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/cr.2011.157","volume":"22","author":"R Rodriguez","year":"2012","unstructured":"Rodriguez R, Rubio R, Menendez P. Modeling sarcomagenesis using multipotent mesenchymal stem cells. Cell Res. 2012;22(1):62\u201377.","journal-title":"Cell Res"},{"issue":"5","key":"6465_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccr.2007.02.027","volume":"11","author":"F Tirode","year":"2007","unstructured":"Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell. 2007;11(5):421\u20139.","journal-title":"Cancer Cell"},{"issue":"13","key":"6465_CR45","first-page":"3464","volume":"63","author":"EC Torchia","year":"2003","unstructured":"Torchia EC, Jaishankar S, Baker SJ. Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res. 2003;63(13):3464\u20138.","journal-title":"Cancer Res"},{"issue":"24","key":"6465_CR46","doi-asserted-by":"publisher","first-page":"11459","DOI":"10.1158\/0008-5472.CAN-05-1696","volume":"65","author":"N Riggi","year":"2005","unstructured":"Riggi N, Cironi L, Provero P, Suva ML, Kaloulis K, Garcia-Echeverria C, Hoffmann F, Trumpp A, Stamenkovic I. Development of Ewing\u2019s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res. 2005;65(24):11459\u201368.","journal-title":"Cancer Res"},{"issue":"19","key":"6465_CR47","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1158\/0008-5472.CAN-05-1704","volume":"65","author":"Y Castillero-Trejo","year":"2005","unstructured":"Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL Jr. Expression of the EWS\/FLI-1 oncogene in murine primary bone-derived cells results in EWS\/FLI-1-dependent, Ewing sarcoma-like tumors. Cancer Res. 2005;65(19):8698\u2013705.","journal-title":"Cancer Res"},{"issue":"3","key":"6465_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semcancer.2005.01.004","volume":"15","author":"H Kovar","year":"2005","unstructured":"Kovar H. Context matters: the hen or egg problem in Ewing\u2019s sarcoma. Semin Cancer Biol. 2005;15(3):189\u201396.","journal-title":"Semin Cancer Biol"},{"issue":"15","key":"6465_CR49","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1073\/pnas.0700690104","volume":"104","author":"JM Funes","year":"2007","unstructured":"Funes JM, Quintero M, Henderson S, Martinez D, Qureshi U, Westwood C, Clements MO, Bourboulia D, Pedley RB, Moncada S, et al. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci U S A. 2007;104(15):6223\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"6465_CR50","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/ng.2800","volume":"45","author":"DA Solomon","year":"2013","unstructured":"Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, et al. Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet. 2013;45(12):1428\u201330.","journal-title":"Nat Genet"},{"issue":"21","key":"6465_CR51","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-14-2744","volume":"21","author":"K Agelopoulos","year":"2015","unstructured":"Agelopoulos K, Richter GH, Schmidt E, Dirksen U, von Heyking K, Moser B, Klein HU, Kontny U, Dugas M, Poos K, et al. Deep sequencing in conjunction with expression and functional analyses reveals activation of FGFR1 in Ewing sarcoma. Clin Cancer Res. 2015;21(21):4935\u201346.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"6465_CR52","doi-asserted-by":"publisher","first-page":"e1004475","DOI":"10.1371\/journal.pgen.1004475","volume":"10","author":"AS Brohl","year":"2014","unstructured":"Brohl AS, Solomon DA, Chang W, Wang J, Song Y, Sindiri S, Patidar R, Hurd L, Chen L, Shern JF, et al. The genomic landscape of the Ewing sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS Genet. 2014;10(7):e1004475.","journal-title":"PLoS Genet"},{"issue":"8","key":"6465_CR53","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2019.07.001","volume":"5","author":"L Romero-Perez","year":"2019","unstructured":"Romero-Perez L, Surdez D, Brunet E, Delattre O, Grunewald TGP. STAG mutations in cancer. Trends Cancer. 2019;5(8):506\u201320.","journal-title":"Trends Cancer"},{"issue":"1","key":"6465_CR54","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41467-019-09659-z","volume":"10","author":"G Mondal","year":"2019","unstructured":"Mondal G, Stevers M, Goode B, Ashworth A, Solomon DA. A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers. Nat Commun. 2019;10(1):1686.","journal-title":"Nat Commun"},{"issue":"3","key":"6465_CR55","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1074\/jbc.M117.806406","volume":"293","author":"P Countryman","year":"2018","unstructured":"Countryman P, Fan Y, Gorthi A, Pan H, Strickland J, Kaur P, Wang X, Lin J, Lei X, White C, et al. Cohesin SA2 is a sequence-independent DNA-binding protein that recognizes DNA replication and repair intermediates. J Biol Chem. 2018;293(3):1054\u201369.","journal-title":"J Biol Chem"},{"issue":"2","key":"6465_CR56","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.molcel.2018.11.001","volume":"73","author":"C Meisenberg","year":"2019","unstructured":"Meisenberg C, Pinder SI, Hopkins SR, Wooller SK, Benstead-Hume G, Pearl FMG, Jeggo PA, Downs JA. Repression of transcription at DNA breaks requires cohesin throughout interphase and prevents genome instability. Mol Cell. 2019;73(2):212\u2013223 e217.","journal-title":"Mol Cell"},{"key":"6465_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13569-019-0122-5","volume":"9","author":"NQ Bui","year":"2019","unstructured":"Bui NQ, Przybyl J, Trabucco SE, Frampton G, Hastie T, van de Rijn M, Ganjoo KN. A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis. Clin Sarcoma Res. 2019;9:12.","journal-title":"Clin Sarcoma Res"},{"issue":"11","key":"6465_CR58","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1084\/jem.20151323","volume":"212","author":"J Mullenders","year":"2015","unstructured":"Mullenders J, Aranda-Orgilles B, Lhoumaud P, Keller M, Pae J, Wang K, Kayembe C, Rocha PP, Raviram R, Gong Y, et al. Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms. J Exp Med. 2015;212(11):1833\u201350.","journal-title":"J Exp Med"},{"issue":"8","key":"6465_CR59","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1074\/jbc.M307663200","volume":"279","author":"E Lara-Pezzi","year":"2004","unstructured":"Lara-Pezzi E, Pezzi N, Prieto I, Barthelemy I, Carreiro C, Martinez A, Maldonado-Rodriguez A, Lopez-Cabrera M, Barbero JL. Evidence of a transcriptional co-activator function of cohesin STAG\/SA\/Scc3. J Biol Chem. 2004;279(8):6553\u20139.","journal-title":"J Biol Chem"},{"issue":"6634","key":"6465_CR60","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/42750","volume":"387","author":"DM Heery","year":"1997","unstructured":"Heery DM, Kalkhoven E, Hoare S, Parker MG. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 1997;387(6634):733\u20136.","journal-title":"Nature"},{"issue":"7","key":"6465_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21037\/atm.2019.02.23","volume":"7","author":"Z Nie","year":"2019","unstructured":"Nie Z, Gao W, Zhang Y, Hou Y, Liu J, Li Z, Xue W, Ye X, Jin A. STAG2 loss-of-function mutation induces PD-L1 expression in U2OS cells. Ann Transl Med. 2019;7(7):127.","journal-title":"Ann Transl Med"},{"issue":"11","key":"6465_CR62","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1101\/gr.136507.111","volume":"22","author":"AJ Faure","year":"2012","unstructured":"Faure AJ, Schmidt D, Watt S, Schwalie PC, Wilson MD, Xu H, Ramsay RG, Odom DT, Flicek P. Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. Genome Res. 2012;22(11):2163\u201375.","journal-title":"Genome Res"},{"issue":"3","key":"6465_CR63","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1073\/pnas.1317788111","volume":"111","author":"J Zuin","year":"2014","unstructured":"Zuin J, Dixon JR, van der Reijden MI, Ye Z, Kolovos P, Brouwer RW, van de Corput MP, van de Werken HJ, Knoch TA, van IJcken WFJ, et al. Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells. Proc Natl Acad Sci U S A. 2014;111(3):996\u20131001.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"6465_CR64","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1158\/0008-5472.CAN-17-1260","volume":"77","author":"Z Daniloski","year":"2017","unstructured":"Daniloski Z, Smith S. Loss of tumor suppressor STAG2 promotes telomere recombination and extends the replicative lifespan of normal human cells. Cancer Res. 2017;77(20):5530\u201342.","journal-title":"Cancer Res"},{"key":"6465_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41525-017-0009-4","volume":"2","author":"FC Soardi","year":"2017","unstructured":"Soardi FC, Machado-Silva A, Linhares ND, Zheng G, Qu Q, Pena HB, Martins TMM, Vieira HGS, Pereira NB, Melo-Minardi RC, et al. Familial STAG2 germline mutation defines a new human cohesinopathy. NPJ Genom Med. 2017;2:7.","journal-title":"NPJ Genom Med"},{"issue":"5","key":"6465_CR66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s10038-019-0571-y","volume":"64","author":"H Aoi","year":"2019","unstructured":"Aoi H, Lei M, Mizuguchi T, Nishioka N, Goto T, Miyama S, Suzuki T, Iwama K, Uchiyama Y, Mitsuhashi S, et al. Nonsense variants in STAG2 result in distinct sex-dependent phenotypes. J Hum Genet. 2019;64(5):487\u201392.","journal-title":"J Hum Genet"},{"issue":"3","key":"6465_CR67","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/1535-7163.MCT-13-0749","volume":"13","author":"ML Bailey","year":"2014","unstructured":"Bailey ML, O\u2019Neil NJ, van Pel DM, Solomon DA, Waldman T, Hieter P. Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition. Mol Cancer Ther. 2014;13(3):724\u201332.","journal-title":"Mol Cancer Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6465-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:18:01Z","timestamp":1609460281000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6465-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6465"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6465-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"7 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the MD Anderson Cancer Center Institutional Animal Care and Use Committee. ACUF #00001165-RN01.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}